Trial intelligence / Profile preview

Low-dose dezocine prophylaxis for remifentanil-induced cough during general anesthesia induction

ChiCTR1900027633Phase 4Not yet recruiting

Sponsor
International Peace Maternity and Child Health Hospital
Start
Nov 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dezocine in cough (2 arms), sponsored by International Peace Maternity and Child Health Hospital. Primary endpoint: Occurrence of remifentanil-induced cough. Planned start Nov 2019; status: not yet recruiting.

02

Drugs

dezocine
03

Conditions

cough

Beyond the preview

Go deeper on ChiCTR1900027633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900027633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call